Therefore, to solve limitation of overcome to TRAIL tolerance in cancer therapy, many researchers have shown that combined treatment with chemotherapeutic agents can increase TRAIL sensitivity, and made an effort to identify TRAIL sensitizers [6,7]. The gene discussed is TNFSF10; the disease is cancer.